Member Info for ogm4

http://www.oilreviewafrica.com/exploration/ghana-on-track-with-six-block-licensing-round-for-oil-and-gas licensing rounds Sep Oct

Tullow July 2018 half-year results: "Overall Tullow is aiming to have five new wells across Jubilee and TEN on-line before the end of the year, increasing production through both facilities. In 2019, the Group intends to drill further wells to sustain and maximise plateau production. Tullow is also evaluating additional exploration acreage in Ghana which will be made available in the upcoming licence round." A lot of activity in the area that's for sure... ADDITIONAL EXPLORATION ACREAGE in Ghana, maybe nextdoors so easy tie-in with existing pipelines ?

Let's see what the interims will bring, in total 5 other main US hospitals should come online this year plus possibly other contracts via the TrueVue platform.

Chairman Mr. Keen seems to be buying a lot of stock lately; he now owns over 54 Million shares of the company currently worth over £770,000 pounds. I can't recall having seen directors buying into their own company so heavily with such large amounts really.

Some of his recent buys:....

22 Jan 14.4 MM shares £180k
26 July 6 MM shares £51k
21 Aug 2 MM shares £16k
21 Aug 1 MM shares £8.5k
22 Aug 1 MM shares £9k
24 Aug 2 MM shares £18k

Note the last 6 of his purchases were done over the last two months i.e. quite recent, equalling to another £100k+ out of free circulation and in total this year over £300k was bought up by management. They must have some faith in the near/ mid term progression of the company! Otherwise I can't explain it.

Volume over the last few weeks is abnormally high, not only in Aug, but also this month Sep already nearly 3x more volume than normal. And we still have two weeks left of Sep... I expect RNS this week with interims and update on new strategy and US sales.

63% free float according to ft

Hemodynamic Monitoring Devices Market Worth $1.4 Billion By 2024

May 2016

https://www.grandviewresearch.com/press-release/global-hemodynamic-monitoring-devices-market

I especially like the following part: "“The TrueVue platform now enables Deltex Medical to market its haemodynamic monitoring technologies into a SIGNIFICANTLY BROADER NUMBER of CLINICAL AREAS in the UK including accident & emergency, awake-surgery and obstetrics.”

The TrueVue platform could potentially open up whole new areas of the haemodynamic/ODM market not only everywhere in the UK but also elsewhere.

2 Million additional cash, 1 Million annual cost reduction, expanding growth through TrueVue platform, recent major contracts in US and 4 MM contract in France, more major US hospitals to follow shortly in H218 and director recently buying millions of shares adding up to 54 Million... make that of what you will.

no worries dealer

More news coming soon:..... "The flagship hospital has now started implementing ODM into its standard operating procedures for both colorectal and urological surgery. The clinicians leading the implementation programme have informed the Company that they expect this to lead to use of 40 to 50 probes a month; furthermore, that the system plans to introduce ODM into the two largest sister hospitals in Q2 2018 and the remaining three hospitals by Q4 2018 by which time the flagship hospital expects to have started to roll ODM usage out into other surgical disciplines. The Company is supporting the implementation from its existing resources with no additional overhead."

The interims will this time also surely include the results of the major new hospital in the USA since Jan this year. "The hospital is a University Teaching Hospital in our Mid-Atlantic sales territory and the flagship site within a six hospital healthcare system. It is ranked amongst the top ten hospitals in the USA." "This is a strategically important account win for Deltex in an important teaching hospital. Successful implementation through the hospital and wider system should help drive our overall US sales growth as well as providing an additional highly rated reference account.   "The results from the hospital's evaluation validate the value our ODM technology offers even in those hospitals that have the very best patient outcomes. It is noteworthy that this US hospital was able to use ODM to improve its patients' recoveries even though its starting points for lengths of stay for these types of surgery were already around half the NHS England average."

TrueVue kicking off since introduction last year... "We have seen a number of new accounts coming on stream in the US market, including a very major one which started using TrueVueTM Doppler as the result of a rigorous and successful evaluation. Our French distributor has been awarded the largest tender which we have seen to date for the use of TrueVueTMDoppler and we have continued to migrate our business towards our multi-modal TrueVueTM System. The TrueVueTM System allows us to refresh our market positioning and through the TrueVueTM System we have the possibility of guidin"g treatment for greater numbers of patients. "In the meantime, the largest ever randomised trial of our core TrueVueTM Doppler technology has been published with excellent results and very broad applicability for patients undergoing surgery who need to be protected from expensive, life-shortening complications. This is further compelling evidence that many of these complications are avoided through the use of TrueVueTMDoppler."

1.50p again... someone's hoovering up these shares continuously it seems like yesterday afternoon... bodes well for Monday

this has to give sooner or later

More information on these initiatives will be set out in the Group's interim results which will be published in September 2018.   § extending Deltex Medical's product offering on the TrueVue platform to facilitate sales into a broader number of clinical areas around the world to increase the size of the Group's addressable market; § focussing on the effectiveness of the Group's sales processes to maximise the sales of high margin, ODM disposable probes; and § husbanding Deltex Medical's cash resources while moving towards cash generation.

Well always good to see the board continues buying their own shares. The chairman currently owns over 54 Million shares ! RNS 28th Aug: Following these transactions, Mr Keen's beneficial ownership is 54,223,410 Ordinary Shares, representing approximately 11 per cent. of Deltex Medical's issued ordinary share capital.

I'm expecting drilling news on Badger anytime soon with these increasing oil prices very close to 80 USD/barrel.

As equipment mobilisation is already ongoing it seems I expect them to start operations somewhere next week possibly.

When do people think the 7-days flow test will start, assuming less than a week rig up ?
Eaarly next week ?...